Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FCH vs 18F-FDG for Detecting Hepatocellular Carcinoma
NCT02074202Phase 3Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Feb 2014
- Primary completion
- Mar 2015
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Pathological diagnosis vs PET/CT scan findings at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT02074202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02074202.